Bibi was diagnosed with high-risk neuroblastoma in 2018 at 2 years old. Bibis's family are urgently fundraising to raise a further £200,000 so she can enrol on a promising clinical trial using engineered T cells called GD2 CART in Rome without delay.
Bibi was diagnosed with high-risk neuroblastoma in 2018 at 2 years old. Bibis's family are urgently fundraising to raise a further £200,000 so she can enrol on a promising clinical trial using engineered T cells called GD2 CART in Rome without delay.
Donations are paid into Solving Kids' Cancer’s general funds for our charitable activities. We help families affected by neuroblastoma through the provision of support and information; as well as investing in research and advocating for access to better treatment